Developing a vaccination program for infectious bursal disease virus (IBDV) challenges should consider the severity and ...

Mississauga: GSK's AREXVY (respiratory syncytial virus vaccine - recombinant, AS01E adjuvanted) has been approved in Canada ...

cDepartment of Emergency Kaohsiung Municipal United Hospital, Kaohsiung City, Taiwan dDepartment of Internal Medicine Kaohsiung Municipal United Hospital, Kaohsiung City, Taiwan On Aug 14, 2024, WHO ...

Loopworm is ramping up production at a facility in Bangalore capable of churning out 6,000t of silkworm and black soldier fly ...

Africa has about 25.9 million (65%) of the global burden with Nigeria contributing about 1.9 million making it the fourth ...

Childhood vaccinations are crucial for protecting children from deadly infections. Vaccines work by stimulating the immune ...

The authors are grateful to the Council of Scientific and Industrial Research (CSIR-CCMB), India, for encouragement and support for this work. NIH Awards (R37DA025576; R01MH085259) also support SK ...

In a report released today, Annabel Samimy from Stifel Nicolaus maintained a Buy rating on RegenXBio (RGNX – Research Report), with a ...

Brian Skorney, an analyst from Robert W. Baird, maintained the Buy rating on RegenXBio (RGNX – Research Report). The associated price ...

The trial will be conducted in the Democratic Republic of the Congo in partnership with Emergent BioSolutions.

By Keith Roach, M.D. TITLE: 63-year-old debates getting shingles and chicken pox vaccines---DEAR DR. ROACH: A few months ago, yo ...